The GALK1 gene helps your body process galactose, a sugar found in milk and some foods. If this gene does not work well, galactose can build up and be turned into substances that cloud the lens of the eye, which may cause cataracts, often in babies or young children. Pathogenic variants in the GALK1 gene cause galactokinase deficiency, a form of galactosemia. Many people with this condition mainly have eye findings rather than the wider health problems seen in some other types of galactosemia.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts that do much of the work inside cells. Others mainly control when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. You can find more detailed information about this topic in the LearnHub.
Overview
GALK1Gene function
What if the gene works
The GALK1 gene helps your body process galactose, a sugar that comes from lactose in milk. It starts the first step of turning this sugar into a form cells can use or store.
Risk
What if the gene does not work
Variants in the GALK1 gene can cause galactokinase deficiency, a form of galactosemia that often leads to early cataracts in babies and children. Milder and more severe variants can affect how much enzyme activity remains and how strongly features appear.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the GALK1 gene, treatment is mainly dietary rather than drug based. Limiting lactose and galactose is the standard management approach and works best when started early. No medication choice is currently guided specifically by the GALK1 gene.
Conditions associated with GALK1
Gene function
What if the gene works
After you eat foods with lactose, part of that sugar becomes galactose. The GALK1 gene helps your cells handle galactose by starting the process that turns it into a usable form. This is part of how the body processes galactose from milk and other foods in everyday life.
The GALK1 gene provides instructions for an enzyme called galactokinase. This enzyme changes galactose into galactose-1-phosphate, which starts the main pathway for using this sugar.
After lactose is broken down during digestion, cells use this gene’s enzyme to handle the galactose portion. That keeps sugar processing moving in an orderly way during normal metabolism.
By attaching a small chemical tag called phosphate, the enzyme prepares galactose for the next steps inside cells. This helps the body direct galactose into routine energy and cell-building pathways.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. These changes are common and help make each person naturally different, including in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of normal genetic variation. At times, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GALK1 gene can lower or switch off galactokinase by altering the protein's shape, stability, or ability to process galactose. This spectrum shows how variants in the GALK1 gene affect enzyme activity, from milder changes that leave some activity to more severe variants that leave little or none. When activity is very low, galactose can build up inside the lens of the eye, and cataracts may appear earlier or be more pronounced.
How variants are linked to conditions
Pathogenic variants in the GALK1 gene cause galactokinase deficiency, also called galactosemia type II. In practical terms, GALK1 gene variants are linked to a condition that most often shows up with cataracts in infancy, sometimes within the first weeks or months of life. Some children are identified through newborn screening, while others come to medical attention because of cloudy lenses or early vision concerns. When disease-causing variants are found in both copies of the GALK1 gene, this can confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GALK1, risk is mainly set by whether someone has disease-causing changes in both copies of the gene. In people living with GALK1-related galactokinase deficiency, regular exposure to galactose, a sugar in milk and some foods, can raise the chance of developing cataracts. There is not enough evidence to say other lifestyle factors meaningfully change the underlying genetic risk.
Inheritance of GALK1 variants
GALK1-related galactokinase deficiency is inherited in an autosomal recessive pattern. This means a child usually inherits one GALK1 variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the GALK1 gene, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variants. In practical terms, how GALK1 variants are inherited depends on both parents passing on the changed copy.
What does my GALK1 result mean for my family?
For GALK1, family members can sometimes carry the same gene change without having symptoms. Brothers and sisters may also have the condition or be carriers, and parents are usually carriers. Close relatives may want to learn whether the same result runs in the family, especially when there is a history of infant cataracts or problems handling milk sugar.
Genetic information
Genetic testing
How you find out about variants
GALK1 genetic testing looks for variants in the GALK1 gene using DNA from a blood sample, saliva, or a cheek swab. A lab reads the gene’s sequence and checks for changes that may help confirm galactokinase deficiency or clarify whether someone carries a familial variant.
When should I consider getting a genetic test?
Genetic testing for the GALK1 gene can be worth considering if a baby develops cataracts very early in life, if newborn screening suggests a problem with breaking down galactose, a sugar in milk, or if this condition runs in the family. A result can help confirm the cause and guide care.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but what they can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem to have little effect in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the response to medications. It studies the relationships between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the GALK1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work, so any concerns about side effects, new symptoms, or medication changes are best discussed with your doctor or pharmacist.
History
GALK1 entered medical genetics through studies of babies and children who developed cataracts early in life without the full picture of classic galactosemia. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition was separated from other forms of inherited problems with galactose in the mid 20th century. From these first observations, research expanded steadily, and doctors learned that not all galactose related conditions had the same course or outlook. The GALK1 gene was later mapped and identified at the DNA level, which made diagnosis more precise for affected families. This history helped turn a puzzling eye finding in infancy into a clearly defined inherited condition.